F2-Isoprostanes Are Associated With Increased Fracture Risk in Type 2 Diabetes. Wang B, Dhaliwal R, Ewing SK, Schwartz AV, et al. J Clin Endocrinol Metab 2024 Nov 8:dgae788. doi: 10.1210.

Read + Share

Amedeo Smart

Independent Medical Education

Wang B, Dhaliwal R, Ewing SK, Schwartz AV, et al. F2-Isoprostanes Are Associated With Increased Fracture Risk in Type 2 Diabetes. J Clin Endocrinol Metab 2024 Nov 8:dgae788. doi: 10.1210.
PMID: 39512199